ABSTRACT
Imperation analogs have the furanocoumarin skeleton, with the isopentenyl group, which displayed significant bioactivities. The biotransformation of furanocoumarins imperation, isoimperation and phellopterin (1-3) by fungi has been proved to be an efficient method for the structural modification. Ten transformed furanocoumarin analogs were obtained by fungal biotransformation, including one new highly oxygenated furanocoumarin (4c). Aspergillus niger AS 3.739 displayed selectively transformed capability toward furanocouamrins (1-3) with one or two major products. So, seven hydroxylation and hydrolysis derivatives have been prepared efficiently. Additionally, the biotransformation of phellopterin gave multiple products (4a, 4b, 4c) by Cunninghamella blakesleana AS 3.970. The biotransformation time-courses of furanocoumarins have been established, which suggested the preferred incubation time. The bioactivities of furanocoumarin analogs have been investigated in an in vitro bioassay. And, furanocoumarins 1-3, 2a, and 2c displayed moderate anti-osteoporosis activities using MCET3-E1 cell line at the concentrations of 1, 10, and 100 µM.
Subject(s)
Fungi/metabolism , Furocoumarins/metabolism , Aspergillus niger/metabolism , Biotransformation , Bone Density Conservation Agents/pharmacology , Cell Line , Culture Media , Cunninghamella/metabolism , Female , Furocoumarins/pharmacology , Humans , Magnetic Resonance Spectroscopy , Molecular Structure , Osteoporosis/drug therapyABSTRACT
Resibufogenin (RB), a major bioactive bufadienolide, has the potential anticancer activity. In the present work, biotransformation of RB by Actinomucor elegans AS 3.2778 yielded five products, namely 3-oxo-resibufogenin (1), 3-epi-resibufogenin (2), 3-epi-12-oxo-hydroxylresibufogenin (3), 3α-acetoxy-15α-hydroxylbufalin (4), and 3-epi-12α-hydroxylresibufogenin (5), respectively. Among them, metabolites 3 and 4 are previously unreported. The chemical structures of metabolites 1-5 were fully elucidated on the basis of 2D NMR and HR-MS. The highly stereo- and regio-specific isomerization, hydroxylation, and esterification reactions were observed in the biotransformation process of RB by A. elegans. Their cytotoxicities against A549 and H1299 cells were evaluated.
Subject(s)
Antineoplastic Agents/metabolism , Bufanolides/metabolism , Mucorales/metabolism , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Biotransformation , Bufanolides/chemistry , Bufanolides/pharmacology , Drug Screening Assays, Antitumor , Humans , Hydroxylation , Molecular Structure , Nuclear Magnetic Resonance, BiomolecularABSTRACT
In this paper, the microbial transformation of resibufogenin by Curvularia lunata AS 3.4381 was investigated, and four transformed products were isolated and characterized as 3-epi-resibufogenin (2), 12α-hydroxy-3-epi-resibufogenin (3), 12-oxo-16ß-hydroxy-3-epi-resibufogenin (4), and 12ß,15-epoxy-3-epi-bufalin-14,15-ene (5). Among them, 4 and 5 are new compounds, and isomerization, hydroxylation, and oxidation reactions in microbial transformation process were observed. Additionally, the cytotoxicities of transformed products (2-5) were also investigated.
Subject(s)
Ascomycota/metabolism , Bufanolides , Ascomycota/chemistry , Bufanolides/chemistry , Bufanolides/isolation & purification , Bufanolides/metabolism , Bufanolides/pharmacology , Drug Screening Assays, Antitumor , Female , HeLa Cells , Humans , Hydroxylation , Isomerism , Molecular Structure , Nuclear Magnetic Resonance, BiomolecularABSTRACT
In this paper, microbial transformation of resibufogenin by Fusarium solani AS 3.1829 was investigated, and five transformed products were isolated and identified as 3-ketone-resibufogenin (2), 3-one-cyclic 3-(1,2-dimethyl-1,2-ethanediylacetal)-resibufogenin (3), 3-dimethoxyl-resibufogenin (4), 3-epi-resibufogenin (5), and 3-epi-15α-hydroxy-7ßH-bufalin (6), respectively. Among them, 3, 4, and 6 are new compounds, and the rare double oxidization of C-3 was reported. In addition, the cytotoxicities of transformed products were also investigated.
Subject(s)
Antineoplastic Agents/metabolism , Bufanolides/metabolism , Fusarium/metabolism , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Biotransformation , Bufanolides/chemistry , Bufanolides/pharmacology , Drug Screening Assays, Antitumor , HeLa Cells , Humans , Molecular Structure , Nuclear Magnetic Resonance, BiomolecularABSTRACT
Resibufogenin is one of the major active components of the Chinese medicine ChanSu. In this paper, microbial transformation of resibufogenin by Absidia coerules AS 3.3382 was investigated and five metabolites were isolated and identified as 5beta-hydroxy-resibufogenin (2), 3-epi-resibufogenin (3), 3alpha-hydroxy-15-oxo-14alphaH-bufa-20, 22-dienolide (4), 3alpha,14alpha,15beta-trihydroxy-bufa-20, 22-dienolide (5) and 3-epi-15beta-hydroxy-bufalin (6). Among them, 4-6 are novel compounds, and compound 3 is a major transformed product. The cytotoxicities of the compounds against Bel-7402 and Hela cells were investigated, and our result suggested that 14,15-OH configuration was directly related to the cytotoxicities of bufadienolides.
Subject(s)
Absidia/metabolism , Bufanolides/metabolism , Antineoplastic Agents/analysis , Biotransformation , Drugs, Chinese Herbal/metabolism , HeLa Cells/drug effects , Humans , Magnetic Resonance SpectroscopyABSTRACT
Two novel lavandulyl flavonoids, (2S)-7-methoxyl-4",5"-dihydroxynorkurarinone (1) and (2S)-6"-hydroxynorkurarinone-7-O-beta-D-galactoside (2), were isolated from the rhizome of Sophora flavescens. Their structures were elucidated by spectral methods, including 2D NMR spectroscopy. Both compounds showed cytotoxic activity against Hela cells, with 2 being more active than 1.
Subject(s)
Flavonoids/isolation & purification , Sophora/chemistry , Flavonoids/chemistry , Flavonoids/pharmacology , HeLa Cells , Humans , Magnetic Resonance Spectroscopy , Structure-Activity RelationshipABSTRACT
The biotransformation of dehydroandrographolide (1) by Cunninghamella elegans was performed and four transformed products were obtained. Based on their extensive spectral data, the structures of these metabolites were identified as 3-oxo-dehydroandrographolide (2), 3-oxo-2beta-hydroxy-dehydroandrographolide (3), 3-oxo-8beta,17alpha-epoxydehydroandrographolide (4), 3,19-dihydroxy-7,11,13-ent-labdatrien-15,16-olide (5), respectively. Among them, products 3-5 are new compounds.
